nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—testicular cancer—ovarian cancer	0.36	0.511	CtDrD
Bleomycin—germ cell cancer—ovarian cancer	0.345	0.489	CtDrD
Bleomycin—LIG1—Mismatch repair—MSH2—ovarian cancer	0.00473	0.0519	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MLH1—ovarian cancer	0.00427	0.0468	CbGpPWpGaD
Bleomycin—LIG1—embryo—ovarian cancer	0.00424	0.0558	CbGeAlD
Bleomycin—LIG1—Homologous Recombination Repair—BRIP1—ovarian cancer	0.00415	0.0455	CbGpPWpGaD
Bleomycin—LIG3—epithelium—ovarian cancer	0.00374	0.0492	CbGeAlD
Bleomycin—LIG3—uterine cervix—ovarian cancer	0.00371	0.0488	CbGeAlD
Bleomycin—BLMH—myometrium—ovarian cancer	0.00356	0.0469	CbGeAlD
Bleomycin—LIG1—Double-Strand Break Repair—BRIP1—ovarian cancer	0.00326	0.0357	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—ovarian cancer	0.00314	0.0345	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—ovarian cancer	0.00314	0.0345	CbGpPWpGaD
Bleomycin—LIG3—gonad—ovarian cancer	0.00311	0.041	CbGeAlD
Bleomycin—LIG1—endometrium—ovarian cancer	0.0031	0.0409	CbGeAlD
Bleomycin—LIG3—uterus—ovarian cancer	0.00309	0.0407	CbGeAlD
Bleomycin—LIG1—MMR—MSH2—ovarian cancer	0.00299	0.0327	CbGpPWpGaD
Bleomycin—LIG1—gonad—ovarian cancer	0.00288	0.0379	CbGeAlD
Bleomycin—LIG1—uterus—ovarian cancer	0.00286	0.0377	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—ovarian cancer	0.00283	0.0311	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—ovarian cancer	0.00283	0.0311	CbGpPWpGaD
Bleomycin—LIG3—female reproductive system—ovarian cancer	0.00278	0.0366	CbGeAlD
Bleomycin—BLMH—uterine cervix—ovarian cancer	0.00277	0.0365	CbGeAlD
Bleomycin—LIG1—MMR—MLH1—ovarian cancer	0.00269	0.0295	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—PALB2—ovarian cancer	0.00269	0.0295	CbGpPWpGaD
Bleomycin—BLMH—decidua—ovarian cancer	0.00264	0.0348	CbGeAlD
Bleomycin—LIG1—female reproductive system—ovarian cancer	0.00257	0.0338	CbGeAlD
Bleomycin—LIG3—female gonad—ovarian cancer	0.00253	0.0333	CbGeAlD
Bleomycin—BLMH—endometrium—ovarian cancer	0.00251	0.033	CbGeAlD
Bleomycin—LIG1—bone marrow—ovarian cancer	0.00243	0.032	CbGeAlD
Bleomycin—LIG3—DNA Repair—BRIP1—ovarian cancer	0.00235	0.0258	CbGpPWpGaD
Bleomycin—LIG1—female gonad—ovarian cancer	0.00234	0.0308	CbGeAlD
Bleomycin—LIG1—vagina—ovarian cancer	0.00233	0.0306	CbGeAlD
Bleomycin—BLMH—gonad—ovarian cancer	0.00233	0.0306	CbGeAlD
Bleomycin—BLMH—uterus—ovarian cancer	0.00231	0.0304	CbGeAlD
Bleomycin—LIG3—testis—ovarian cancer	0.00224	0.0295	CbGeAlD
Bleomycin—LIG1—Chromosome Maintenance—RSF1—ovarian cancer	0.00223	0.0244	CbGpPWpGaD
Bleomycin—BLMH—female reproductive system—ovarian cancer	0.00208	0.0273	CbGeAlD
Bleomycin—LIG1—testis—ovarian cancer	0.00207	0.0273	CbGeAlD
Bleomycin—BLMH—bone marrow—ovarian cancer	0.00196	0.0258	CbGeAlD
Bleomycin—LIG1—Homologous Recombination Repair—BRCA1—ovarian cancer	0.00194	0.0213	CbGpPWpGaD
Bleomycin—BLMH—female gonad—ovarian cancer	0.00189	0.0249	CbGeAlD
Bleomycin—BLMH—vagina—ovarian cancer	0.00188	0.0247	CbGeAlD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—ERCC1—ovarian cancer	0.00181	0.0198	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—ERCC1—ovarian cancer	0.00178	0.0195	CbGpPWpGaD
Bleomycin—LIG1—Homologous Recombination Repair—BRCA2—ovarian cancer	0.00176	0.0193	CbGpPWpGaD
Bleomycin—BLMH—testis—ovarian cancer	0.00168	0.0221	CbGeAlD
Bleomycin—LIG3—lymph node—ovarian cancer	0.00163	0.0214	CbGeAlD
Bleomycin—LIG3—DNA Repair—MSH2—ovarian cancer	0.00161	0.0177	CbGpPWpGaD
Bleomycin—LIG1—Double-Strand Break Repair—BRCA1—ovarian cancer	0.00153	0.0167	CbGpPWpGaD
Bleomycin—LIG1—lymph node—ovarian cancer	0.0015	0.0198	CbGeAlD
Bleomycin—LIG3—DNA Repair—MLH1—ovarian cancer	0.00145	0.0159	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—ERCC1—ovarian cancer	0.00144	0.0158	CbGpPWpGaD
Bleomycin—LIG1—Double-Strand Break Repair—BRCA2—ovarian cancer	0.00138	0.0151	CbGpPWpGaD
Bleomycin—LIG1—Nucleotide Excision Repair—ERCC1—ovarian cancer	0.00133	0.0146	CbGpPWpGaD
Bleomycin—LIG1—Vindesine—Vinorelbine—ovarian cancer	0.0013	0.363	CbGdCrCtD
Bleomycin—LIG1—HIV Life Cycle—CHMP4C—ovarian cancer	0.00122	0.0134	CbGpPWpGaD
Bleomycin—BLMH—lymph node—ovarian cancer	0.00121	0.016	CbGeAlD
Bleomycin—LIG3—DNA Repair—BRCA1—ovarian cancer	0.0011	0.0121	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—PALB2—ovarian cancer	0.00104	0.0114	CbGpPWpGaD
Bleomycin—LIG1—Paclitaxel—Docetaxel—ovarian cancer	0.00102	0.285	CbGdCrCtD
Bleomycin—LIG3—DNA Repair—BRCA2—ovarian cancer	0.000995	0.0109	CbGpPWpGaD
Bleomycin—LIG1—Extension of Telomeres—TERT—ovarian cancer	0.00095	0.0104	CbGpPWpGaD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—ovarian cancer	0.000916	0.01	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—BRIP1—ovarian cancer	0.000912	0.01	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—CHMP4C—ovarian cancer	0.000843	0.00924	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000841	0.00922	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—PARK2—ovarian cancer	0.000786	0.00862	CbGpPWpGaD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—SKP2—ovarian cancer	0.000786	0.00861	CbGpPWpGaD
Bleomycin—LIG1—Vincristine—Vinorelbine—ovarian cancer	0.000699	0.196	CbGdCrCtD
Bleomycin—LIG1—DNA Repair—ERCC1—ovarian cancer	0.000691	0.00758	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000686	0.00752	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—SKP2—ovarian cancer	0.000674	0.00739	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MSH2—ovarian cancer	0.000625	0.00685	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RSF1—ovarian cancer	0.000565	0.0062	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MLH1—ovarian cancer	0.000563	0.00618	CbGpPWpGaD
Bleomycin—LIG1—Vinblastine—Vinorelbine—ovarian cancer	0.000562	0.157	CbGdCrCtD
Bleomycin—LIG1—S Phase—SKP2—ovarian cancer	0.000521	0.00571	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PVRL2—ovarian cancer	0.000456	0.005	CbGpPWpGaD
Bleomycin—LIG1—Telomere Maintenance—TERT—ovarian cancer	0.00043	0.00472	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—BRCA1—ovarian cancer	0.000427	0.00468	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PARK2—ovarian cancer	0.000389	0.00427	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—BRCA2—ovarian cancer	0.000386	0.00423	CbGpPWpGaD
Bleomycin—LIG1—Chromosome Maintenance—TERT—ovarian cancer	0.000359	0.00393	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCNE1—ovarian cancer	0.00035	0.00383	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—IKBKG—ovarian cancer	0.000341	0.00374	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—EREG—ovarian cancer	0.000341	0.00374	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—SKP2—ovarian cancer	0.000334	0.00366	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000328	0.00359	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000299	0.00328	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RAD51C—ovarian cancer	0.000297	0.00325	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.00029	0.00318	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000281	0.00308	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PVRL2—ovarian cancer	0.000276	0.00303	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000266	0.00292	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—PPP1CC—ovarian cancer	0.000259	0.00284	CbGpPWpGaD
Bleomycin—LIG1—Disease—HSD17B6—ovarian cancer	0.000258	0.00283	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000254	0.00278	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000246	0.00269	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000246	0.00269	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000241	0.00265	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PPP2R1A—ovarian cancer	0.000241	0.00264	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RBL2—ovarian cancer	0.000238	0.00261	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PARK2—ovarian cancer	0.000236	0.00259	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—CDKN1B—ovarian cancer	0.000221	0.00242	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD8A—ovarian cancer	0.000215	0.00236	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—CDKN1B—ovarian cancer	0.000207	0.00227	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IKBKG—ovarian cancer	0.000207	0.00227	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EREG—ovarian cancer	0.000207	0.00227	CbGpPWpGaD
Bleomycin—LIG1—Disease—CHMP4C—ovarian cancer	0.000207	0.00226	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SKP2—ovarian cancer	0.000202	0.00222	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000187	0.00206	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CDKN1B—ovarian cancer	0.000181	0.00199	CbGpPWpGaD
Bleomycin—LIG1—Disease—BCL9—ovarian cancer	0.000179	0.00196	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000179	0.00143	CcSEcCtD
Bleomycin—Anaemia—Vinorelbine—ovarian cancer	0.000178	0.00142	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000177	0.00194	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000177	0.00194	CbGpPWpGaD
Bleomycin—Pancytopenia—Paclitaxel—ovarian cancer	0.000177	0.00141	CcSEcCtD
Bleomycin—Pain—Chlorambucil—ovarian cancer	0.000177	0.00141	CcSEcCtD
Bleomycin—Thrombocytopenia—Melphalan—ovarian cancer	0.000176	0.00141	CcSEcCtD
Bleomycin—Anorexia—Topotecan—ovarian cancer	0.000175	0.0014	CcSEcCtD
Bleomycin—Malaise—Vinorelbine—ovarian cancer	0.000174	0.00139	CcSEcCtD
Bleomycin—LIG1—S Phase—CCND1—ovarian cancer	0.000173	0.0019	CbGpPWpGaD
Bleomycin—Leukopenia—Vinorelbine—ovarian cancer	0.000173	0.00138	CcSEcCtD
Bleomycin—Anorexia—Melphalan—ovarian cancer	0.000172	0.00137	CcSEcCtD
Bleomycin—Feeling abnormal—Chlorambucil—ovarian cancer	0.00017	0.00136	CcSEcCtD
Bleomycin—Weight decreased—Paclitaxel—ovarian cancer	0.000168	0.00135	CcSEcCtD
Bleomycin—Hypotension—Melphalan—ovarian cancer	0.000168	0.00135	CcSEcCtD
Bleomycin—Cough—Vinorelbine—ovarian cancer	0.000168	0.00134	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000168	0.00134	CcSEcCtD
Bleomycin—Pneumonia—Paclitaxel—ovarian cancer	0.000167	0.00133	CcSEcCtD
Bleomycin—Ulcer—Doxorubicin—ovarian cancer	0.000166	0.00133	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—ovarian cancer	0.000166	0.00132	CcSEcCtD
Bleomycin—Paraesthesia—Topotecan—ovarian cancer	0.000165	0.00132	CcSEcCtD
Bleomycin—Urticaria—Chlorambucil—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Chest pain—Vinorelbine—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Myalgia—Vinorelbine—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Dyspnoea—Topotecan—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000164	0.00131	CcSEcCtD
Bleomycin—Body temperature increased—Chlorambucil—ovarian cancer	0.000163	0.00131	CcSEcCtD
Bleomycin—Myocardial infarction—Paclitaxel—ovarian cancer	0.000163	0.0013	CcSEcCtD
Bleomycin—Discomfort—Vinorelbine—ovarian cancer	0.000162	0.0013	CcSEcCtD
Bleomycin—Skin exfoliation—Epirubicin—ovarian cancer	0.000162	0.00129	CcSEcCtD
Bleomycin—Stomatitis—Paclitaxel—ovarian cancer	0.000162	0.00129	CcSEcCtD
Bleomycin—Paraesthesia—Melphalan—ovarian cancer	0.000162	0.00129	CcSEcCtD
Bleomycin—Dyspnoea—Melphalan—ovarian cancer	0.000161	0.00128	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH1—ovarian cancer	0.00016	0.00176	CbGpPWpGaD
Bleomycin—Decreased appetite—Topotecan—ovarian cancer	0.00016	0.00128	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—SKP2—ovarian cancer	0.000158	0.00174	CbGpPWpGaD
Bleomycin—Haematuria—Paclitaxel—ovarian cancer	0.000158	0.00126	CcSEcCtD
Bleomycin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000157	0.00126	CcSEcCtD
Bleomycin—Pain—Topotecan—ovarian cancer	0.000157	0.00126	CcSEcCtD
Bleomycin—Decreased appetite—Melphalan—ovarian cancer	0.000157	0.00125	CcSEcCtD
Bleomycin—Infection—Vinorelbine—ovarian cancer	0.000156	0.00125	CcSEcCtD
Bleomycin—Bronchospasm—Docetaxel—ovarian cancer	0.000155	0.00124	CcSEcCtD
Bleomycin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000154	0.00123	CcSEcCtD
Bleomycin—Pain—Melphalan—ovarian cancer	0.000154	0.00123	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—ovarian cancer	0.000153	0.00123	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—ovarian cancer	0.000153	0.00123	CcSEcCtD
Bleomycin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000152	0.00122	CcSEcCtD
Bleomycin—Feeling abnormal—Topotecan—ovarian cancer	0.000152	0.00121	CcSEcCtD
Bleomycin—Cystitis—Doxorubicin—ovarian cancer	0.000152	0.00121	CcSEcCtD
Bleomycin—Anorexia—Vinorelbine—ovarian cancer	0.00015	0.0012	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—ovarian cancer	0.00015	0.0012	CcSEcCtD
Bleomycin—Pancytopenia—Docetaxel—ovarian cancer	0.00015	0.0012	CcSEcCtD
Bleomycin—Haemoglobin—Paclitaxel—ovarian cancer	0.00015	0.0012	CcSEcCtD
Bleomycin—Haemorrhage—Paclitaxel—ovarian cancer	0.000149	0.00119	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDH1—ovarian cancer	0.000149	0.00163	CbGpPWpGaD
Bleomycin—Asthenia—Chlorambucil—ovarian cancer	0.000148	0.00119	CcSEcCtD
Bleomycin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000148	0.00118	CcSEcCtD
Bleomycin—Hypotension—Vinorelbine—ovarian cancer	0.000147	0.00118	CcSEcCtD
Bleomycin—BLMH—Immune System—PPP2R1A—ovarian cancer	0.000146	0.0016	CbGpPWpGaD
Bleomycin—Pruritus—Chlorambucil—ovarian cancer	0.000146	0.00117	CcSEcCtD
Bleomycin—Urticaria—Topotecan—ovarian cancer	0.000146	0.00117	CcSEcCtD
Bleomycin—Body temperature increased—Topotecan—ovarian cancer	0.000145	0.00116	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000143	0.00115	CcSEcCtD
Bleomycin—Urticaria—Melphalan—ovarian cancer	0.000143	0.00114	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—ovarian cancer	0.000143	0.00114	CcSEcCtD
Bleomycin—Weight decreased—Docetaxel—ovarian cancer	0.000143	0.00114	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PIK3CD—ovarian cancer	0.000142	0.00156	CbGpPWpGaD
Bleomycin—Bladder pain—Doxorubicin—ovarian cancer	0.000142	0.00113	CcSEcCtD
Bleomycin—Pneumonia—Docetaxel—ovarian cancer	0.000141	0.00113	CcSEcCtD
Bleomycin—Paraesthesia—Vinorelbine—ovarian cancer	0.000141	0.00113	CcSEcCtD
Bleomycin—Dyspnoea—Vinorelbine—ovarian cancer	0.00014	0.00112	CcSEcCtD
Bleomycin—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000139	0.00111	CcSEcCtD
Bleomycin—LIG1—S Phase—MYC—ovarian cancer	0.000139	0.00152	CbGpPWpGaD
Bleomycin—Flushing—Paclitaxel—ovarian cancer	0.000138	0.00111	CcSEcCtD
Bleomycin—Myocardial infarction—Docetaxel—ovarian cancer	0.000138	0.0011	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000138	0.00151	CbGpPWpGaD
Bleomycin—Stomatitis—Docetaxel—ovarian cancer	0.000137	0.0011	CcSEcCtD
Bleomycin—Decreased appetite—Vinorelbine—ovarian cancer	0.000137	0.00109	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000136	0.00149	CbGpPWpGaD
Bleomycin—Hypersensitivity—Topotecan—ovarian cancer	0.000136	0.00108	CcSEcCtD
Bleomycin—Pain—Vinorelbine—ovarian cancer	0.000135	0.00108	CcSEcCtD
Bleomycin—Chills—Paclitaxel—ovarian cancer	0.000134	0.00107	CcSEcCtD
Bleomycin—LIG1—Disease—PPP1CC—ovarian cancer	0.000133	0.00146	CbGpPWpGaD
Bleomycin—Hypersensitivity—Melphalan—ovarian cancer	0.000133	0.00106	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—ovarian cancer	0.000132	0.00106	CcSEcCtD
Bleomycin—Asthenia—Topotecan—ovarian cancer	0.000132	0.00106	CcSEcCtD
Bleomycin—Alopecia—Paclitaxel—ovarian cancer	0.000132	0.00105	CcSEcCtD
Bleomycin—Vomiting—Chlorambucil—ovarian cancer	0.000131	0.00105	CcSEcCtD
Bleomycin—BLMH—Immune System—CD8A—ovarian cancer	0.00013	0.00143	CbGpPWpGaD
Bleomycin—Pruritus—Topotecan—ovarian cancer	0.00013	0.00104	CcSEcCtD
Bleomycin—Erythema—Paclitaxel—ovarian cancer	0.00013	0.00104	CcSEcCtD
Bleomycin—Feeling abnormal—Vinorelbine—ovarian cancer	0.00013	0.00104	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CHEK2—ovarian cancer	0.00013	0.00142	CbGpPWpGaD
Bleomycin—Asthenia—Melphalan—ovarian cancer	0.000129	0.00103	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000128	0.00141	CbGpPWpGaD
Bleomycin—Pruritus—Melphalan—ovarian cancer	0.000127	0.00102	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000127	0.0014	CbGpPWpGaD
Bleomycin—Haemoglobin—Docetaxel—ovarian cancer	0.000127	0.00101	CcSEcCtD
Bleomycin—Haemorrhage—Docetaxel—ovarian cancer	0.000126	0.00101	CcSEcCtD
Bleomycin—Hypoaesthesia—Docetaxel—ovarian cancer	0.000126	0.001	CcSEcCtD
Bleomycin—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000126	0.001	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—ERBB2—ovarian cancer	0.000125	0.00137	CbGpPWpGaD
Bleomycin—Urticaria—Vinorelbine—ovarian cancer	0.000125	0.000999	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000125	0.00137	CbGpPWpGaD
Bleomycin—Body temperature increased—Vinorelbine—ovarian cancer	0.000124	0.000994	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—MTOR—ovarian cancer	0.000124	0.00136	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CB—ovarian cancer	0.000124	0.00136	CbGpPWpGaD
Bleomycin—Nausea—Chlorambucil—ovarian cancer	0.000123	0.000981	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000122	0.00133	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND2—ovarian cancer	0.000121	0.00133	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—BRCA1—ovarian cancer	0.000121	0.00133	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.00012	0.00132	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00012	0.000962	CcSEcCtD
Bleomycin—Anaemia—Paclitaxel—ovarian cancer	0.00012	0.000958	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000119	0.0013	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000117	0.00129	CbGpPWpGaD
Bleomycin—Flushing—Docetaxel—ovarian cancer	0.000117	0.000937	CcSEcCtD
Bleomycin—Vomiting—Topotecan—ovarian cancer	0.000117	0.000935	CcSEcCtD
Bleomycin—Malaise—Paclitaxel—ovarian cancer	0.000117	0.000935	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000117	0.00128	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000116	0.000929	CcSEcCtD
Bleomycin—Leukopenia—Paclitaxel—ovarian cancer	0.000116	0.000928	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1B—ovarian cancer	0.000116	0.00127	CbGpPWpGaD
Bleomycin—Rash—Topotecan—ovarian cancer	0.000116	0.000927	CcSEcCtD
Bleomycin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000116	0.000927	CcSEcCtD
Bleomycin—Dermatitis—Topotecan—ovarian cancer	0.000116	0.000926	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—PPP2R1A—ovarian cancer	0.000115	0.00126	CbGpPWpGaD
Bleomycin—Vomiting—Melphalan—ovarian cancer	0.000115	0.000915	CcSEcCtD
Bleomycin—Rash—Melphalan—ovarian cancer	0.000114	0.000908	CcSEcCtD
Bleomycin—Dermatitis—Melphalan—ovarian cancer	0.000113	0.000907	CcSEcCtD
Bleomycin—Chills—Docetaxel—ovarian cancer	0.000113	0.000906	CcSEcCtD
Bleomycin—Cough—Paclitaxel—ovarian cancer	0.000113	0.000905	CcSEcCtD
Bleomycin—Asthenia—Vinorelbine—ovarian cancer	0.000113	0.000903	CcSEcCtD
Bleomycin—Alopecia—Docetaxel—ovarian cancer	0.000112	0.000892	CcSEcCtD
Bleomycin—Pruritus—Vinorelbine—ovarian cancer	0.000111	0.00089	CcSEcCtD
Bleomycin—Myalgia—Paclitaxel—ovarian cancer	0.00011	0.000883	CcSEcCtD
Bleomycin—Chest pain—Paclitaxel—ovarian cancer	0.00011	0.000883	CcSEcCtD
Bleomycin—Erythema—Docetaxel—ovarian cancer	0.00011	0.000879	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BRCA2—ovarian cancer	0.00011	0.0012	CbGpPWpGaD
Bleomycin—Nausea—Topotecan—ovarian cancer	0.000109	0.000873	CcSEcCtD
Bleomycin—Discomfort—Paclitaxel—ovarian cancer	0.000109	0.000872	CcSEcCtD
Bleomycin—Nausea—Melphalan—ovarian cancer	0.000107	0.000855	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PTEN—ovarian cancer	0.000107	0.00117	CbGpPWpGaD
Bleomycin—Confusional state—Paclitaxel—ovarian cancer	0.000107	0.000853	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CCNE1—ovarian cancer	0.000106	0.00117	CbGpPWpGaD
Bleomycin—BLMH—Immune System—TLR4—ovarian cancer	0.000106	0.00117	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000106	0.00116	CbGpPWpGaD
Bleomycin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000106	0.000846	CcSEcCtD
Bleomycin—Oedema—Paclitaxel—ovarian cancer	0.000106	0.000846	CcSEcCtD
Bleomycin—Infection—Paclitaxel—ovarian cancer	0.000105	0.000841	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	0.000105	0.00115	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TYMS—ovarian cancer	0.000104	0.00115	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000104	0.000828	CcSEcCtD
Bleomycin—BLMH—Immune System—IL6ST—ovarian cancer	0.000102	0.00112	CbGpPWpGaD
Bleomycin—Anaemia—Docetaxel—ovarian cancer	0.000102	0.000812	CcSEcCtD
Bleomycin—Pancytopenia—Epirubicin—ovarian cancer	0.000101	0.000808	CcSEcCtD
Bleomycin—Anorexia—Paclitaxel—ovarian cancer	0.000101	0.000806	CcSEcCtD
Bleomycin—LIG1—Disease—HDAC6—ovarian cancer	0.000101	0.00111	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.0001	0.0011	CbGpPWpGaD
Bleomycin—Vomiting—Vinorelbine—ovarian cancer	0.0001	0.0008	CcSEcCtD
Bleomycin—Rash—Vinorelbine—ovarian cancer	9.92e-05	0.000793	CcSEcCtD
Bleomycin—Dermatitis—Vinorelbine—ovarian cancer	9.91e-05	0.000792	CcSEcCtD
Bleomycin—Hypotension—Paclitaxel—ovarian cancer	9.89e-05	0.000791	CcSEcCtD
Bleomycin—Leukopenia—Docetaxel—ovarian cancer	9.84e-05	0.000787	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	9.75e-05	0.00107	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	9.64e-05	0.000771	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—ovarian cancer	9.63e-05	0.00077	CcSEcCtD
Bleomycin—Cough—Docetaxel—ovarian cancer	9.59e-05	0.000767	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—ovarian cancer	9.54e-05	0.000763	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.54e-05	0.00105	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.54e-05	0.00105	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NRAS—ovarian cancer	9.53e-05	0.00105	CbGpPWpGaD
Bleomycin—Paraesthesia—Paclitaxel—ovarian cancer	9.5e-05	0.00076	CcSEcCtD
Bleomycin—Dyspnoea—Paclitaxel—ovarian cancer	9.43e-05	0.000754	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BIRC5—ovarian cancer	9.4e-05	0.00103	CbGpPWpGaD
Bleomycin—Chest pain—Docetaxel—ovarian cancer	9.36e-05	0.000748	CcSEcCtD
Bleomycin—Myalgia—Docetaxel—ovarian cancer	9.36e-05	0.000748	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—ovarian cancer	9.35e-05	0.000747	CcSEcCtD
Bleomycin—Nausea—Vinorelbine—ovarian cancer	9.35e-05	0.000747	CcSEcCtD
Bleomycin—Stomatitis—Epirubicin—ovarian cancer	9.25e-05	0.000739	CcSEcCtD
Bleomycin—Decreased appetite—Paclitaxel—ovarian cancer	9.2e-05	0.000735	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TERT—ovarian cancer	9.1e-05	0.000998	CbGpPWpGaD
Bleomycin—Pain—Paclitaxel—ovarian cancer	9.05e-05	0.000724	CcSEcCtD
Bleomycin—Haematuria—Epirubicin—ovarian cancer	9.04e-05	0.000723	CcSEcCtD
Bleomycin—Confusional state—Docetaxel—ovarian cancer	9.04e-05	0.000723	CcSEcCtD
Bleomycin—BLMH—Immune System—CDH1—ovarian cancer	9.01e-05	0.000988	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.01e-05	0.000988	CbGpPWpGaD
Bleomycin—Anaphylactic shock—Docetaxel—ovarian cancer	8.97e-05	0.000717	CcSEcCtD
Bleomycin—Oedema—Docetaxel—ovarian cancer	8.97e-05	0.000717	CcSEcCtD
Bleomycin—Infection—Docetaxel—ovarian cancer	8.91e-05	0.000712	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—ovarian cancer	8.91e-05	0.000712	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—ovarian cancer	8.83e-05	0.000706	CcSEcCtD
Bleomycin—Thrombocytopenia—Docetaxel—ovarian cancer	8.78e-05	0.000702	CcSEcCtD
Bleomycin—LIG1—Disease—XIAP—ovarian cancer	8.75e-05	0.000959	CbGpPWpGaD
Bleomycin—Feeling abnormal—Paclitaxel—ovarian cancer	8.72e-05	0.000697	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—EGFR—ovarian cancer	8.69e-05	0.000952	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CD—ovarian cancer	8.61e-05	0.000944	CbGpPWpGaD
Bleomycin—Haemoglobin—Epirubicin—ovarian cancer	8.56e-05	0.000684	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—ovarian cancer	8.56e-05	0.000684	CcSEcCtD
Bleomycin—Anorexia—Docetaxel—ovarian cancer	8.55e-05	0.000684	CcSEcCtD
Bleomycin—LIG1—Disease—SMARCA4—ovarian cancer	8.52e-05	0.000934	CbGpPWpGaD
Bleomycin—Haemorrhage—Epirubicin—ovarian cancer	8.52e-05	0.000681	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—ovarian cancer	8.47e-05	0.000677	CcSEcCtD
Bleomycin—Urticaria—Paclitaxel—ovarian cancer	8.41e-05	0.000672	CcSEcCtD
Bleomycin—Hypotension—Docetaxel—ovarian cancer	8.38e-05	0.00067	CcSEcCtD
Bleomycin—Haematuria—Doxorubicin—ovarian cancer	8.37e-05	0.000669	CcSEcCtD
Bleomycin—Body temperature increased—Paclitaxel—ovarian cancer	8.37e-05	0.000669	CcSEcCtD
Bleomycin—LIG1—Disease—EREG—ovarian cancer	8.32e-05	0.000912	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.28e-05	0.000907	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KRAS—ovarian cancer	8.21e-05	0.0009	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	8.17e-05	0.000653	CcSEcCtD
Bleomycin—Paraesthesia—Docetaxel—ovarian cancer	8.05e-05	0.000644	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.01e-05	0.000878	CbGpPWpGaD
Bleomycin—Dyspnoea—Docetaxel—ovarian cancer	8e-05	0.000639	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—ovarian cancer	7.92e-05	0.000633	CcSEcCtD
Bleomycin—Flushing—Epirubicin—ovarian cancer	7.9e-05	0.000632	CcSEcCtD
Bleomycin—Haemorrhage—Doxorubicin—ovarian cancer	7.88e-05	0.00063	CcSEcCtD
Bleomycin—Hypoaesthesia—Doxorubicin—ovarian cancer	7.84e-05	0.000627	CcSEcCtD
Bleomycin—Decreased appetite—Docetaxel—ovarian cancer	7.8e-05	0.000623	CcSEcCtD
Bleomycin—Hypersensitivity—Paclitaxel—ovarian cancer	7.8e-05	0.000623	CcSEcCtD
Bleomycin—Pain—Docetaxel—ovarian cancer	7.67e-05	0.000613	CcSEcCtD
Bleomycin—Chills—Epirubicin—ovarian cancer	7.64e-05	0.000611	CcSEcCtD
Bleomycin—BLMH—Immune System—ERBB2—ovarian cancer	7.6e-05	0.000833	CbGpPWpGaD
Bleomycin—Asthenia—Paclitaxel—ovarian cancer	7.59e-05	0.000607	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—ovarian cancer	7.54e-05	0.000827	CbGpPWpGaD
Bleomycin—Alopecia—Epirubicin—ovarian cancer	7.53e-05	0.000602	CcSEcCtD
Bleomycin—BLMH—Immune System—PIK3CB—ovarian cancer	7.5e-05	0.000822	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MTOR—ovarian cancer	7.5e-05	0.000822	CbGpPWpGaD
Bleomycin—Pruritus—Paclitaxel—ovarian cancer	7.49e-05	0.000599	CcSEcCtD
Bleomycin—Erythema—Epirubicin—ovarian cancer	7.41e-05	0.000593	CcSEcCtD
Bleomycin—Feeling abnormal—Docetaxel—ovarian cancer	7.39e-05	0.000591	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—ovarian cancer	7.31e-05	0.000585	CcSEcCtD
Bleomycin—LIG1—Disease—FASN—ovarian cancer	7.28e-05	0.000798	CbGpPWpGaD
Bleomycin—LIG1—Disease—PARP1—ovarian cancer	7.25e-05	0.000795	CbGpPWpGaD
Bleomycin—Body temperature increased—Docetaxel—ovarian cancer	7.09e-05	0.000567	CcSEcCtD
Bleomycin—Chills—Doxorubicin—ovarian cancer	7.07e-05	0.000565	CcSEcCtD
Bleomycin—BLMH—Immune System—CDKN1B—ovarian cancer	7.04e-05	0.000772	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HRAS—ovarian cancer	6.98e-05	0.000765	CbGpPWpGaD
Bleomycin—Alopecia—Doxorubicin—ovarian cancer	6.96e-05	0.000557	CcSEcCtD
Bleomycin—LIG1—Disease—SLC2A1—ovarian cancer	6.91e-05	0.000758	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL2—ovarian cancer	6.89e-05	0.000755	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Epirubicin—ovarian cancer	6.88e-05	0.00055	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—ovarian cancer	6.86e-05	0.000548	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—ovarian cancer	6.85e-05	0.000548	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.76e-05	0.000741	CbGpPWpGaD
Bleomycin—Vomiting—Paclitaxel—ovarian cancer	6.73e-05	0.000538	CcSEcCtD
Bleomycin—Malaise—Epirubicin—ovarian cancer	6.69e-05	0.000534	CcSEcCtD
Bleomycin—Rash—Paclitaxel—ovarian cancer	6.67e-05	0.000533	CcSEcCtD
Bleomycin—Dermatitis—Paclitaxel—ovarian cancer	6.67e-05	0.000533	CcSEcCtD
Bleomycin—BLMH—Immune System—CTNNB1—ovarian cancer	6.65e-05	0.000729	CbGpPWpGaD
Bleomycin—Leukopenia—Epirubicin—ovarian cancer	6.64e-05	0.000531	CcSEcCtD
Bleomycin—Hypersensitivity—Docetaxel—ovarian cancer	6.61e-05	0.000528	CcSEcCtD
Bleomycin—BLMH—Immune System—PTEN—ovarian cancer	6.48e-05	0.000711	CbGpPWpGaD
Bleomycin—Cough—Epirubicin—ovarian cancer	6.47e-05	0.000517	CcSEcCtD
Bleomycin—Asthenia—Docetaxel—ovarian cancer	6.44e-05	0.000515	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—ovarian cancer	6.36e-05	0.000509	CcSEcCtD
Bleomycin—Pruritus—Docetaxel—ovarian cancer	6.35e-05	0.000507	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—ovarian cancer	6.34e-05	0.000507	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—ovarian cancer	6.31e-05	0.000505	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—ovarian cancer	6.31e-05	0.000505	CcSEcCtD
Bleomycin—Nausea—Paclitaxel—ovarian cancer	6.29e-05	0.000503	CcSEcCtD
Bleomycin—Discomfort—Epirubicin—ovarian cancer	6.24e-05	0.000499	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—ovarian cancer	6.19e-05	0.000495	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	6.17e-05	0.000676	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—ovarian cancer	6.16e-05	0.000675	CbGpPWpGaD
Bleomycin—Leukopenia—Doxorubicin—ovarian cancer	6.14e-05	0.000491	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—ovarian cancer	6.1e-05	0.000488	CcSEcCtD
Bleomycin—Oedema—Epirubicin—ovarian cancer	6.05e-05	0.000484	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—ovarian cancer	6.05e-05	0.000484	CcSEcCtD
Bleomycin—Infection—Epirubicin—ovarian cancer	6.01e-05	0.000481	CcSEcCtD
Bleomycin—Cough—Doxorubicin—ovarian cancer	5.99e-05	0.000479	CcSEcCtD
Bleomycin—Thrombocytopenia—Epirubicin—ovarian cancer	5.92e-05	0.000474	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.88e-05	0.000645	CbGpPWpGaD
Bleomycin—LIG1—Disease—PPP2R1A—ovarian cancer	5.88e-05	0.000644	CbGpPWpGaD
Bleomycin—Chest pain—Doxorubicin—ovarian cancer	5.84e-05	0.000467	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—ovarian cancer	5.84e-05	0.000467	CcSEcCtD
Bleomycin—BLMH—Immune System—STAT3—ovarian cancer	5.8e-05	0.000636	CbGpPWpGaD
Bleomycin—BLMH—Immune System—NRAS—ovarian cancer	5.78e-05	0.000634	CbGpPWpGaD
Bleomycin—Discomfort—Doxorubicin—ovarian cancer	5.77e-05	0.000461	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—ovarian cancer	5.77e-05	0.000461	CcSEcCtD
Bleomycin—Vomiting—Docetaxel—ovarian cancer	5.7e-05	0.000456	CcSEcCtD
Bleomycin—Rash—Docetaxel—ovarian cancer	5.66e-05	0.000452	CcSEcCtD
Bleomycin—Hypotension—Epirubicin—ovarian cancer	5.65e-05	0.000452	CcSEcCtD
Bleomycin—Dermatitis—Docetaxel—ovarian cancer	5.65e-05	0.000452	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—ovarian cancer	5.64e-05	0.000451	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—ovarian cancer	5.6e-05	0.000448	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—ovarian cancer	5.6e-05	0.000448	CcSEcCtD
Bleomycin—Infection—Doxorubicin—ovarian cancer	5.56e-05	0.000445	CcSEcCtD
Bleomycin—BLMH—Immune System—MAPK3—ovarian cancer	5.54e-05	0.000607	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1B—ovarian cancer	5.51e-05	0.000605	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.51e-05	0.000441	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—ovarian cancer	5.48e-05	0.000438	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—ovarian cancer	5.43e-05	0.000434	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—ovarian cancer	5.39e-05	0.000431	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—ovarian cancer	5.34e-05	0.000427	CcSEcCtD
Bleomycin—Nausea—Docetaxel—ovarian cancer	5.33e-05	0.000426	CcSEcCtD
Bleomycin—BLMH—Immune System—MAPK1—ovarian cancer	5.27e-05	0.000578	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGFR—ovarian cancer	5.27e-05	0.000578	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—ovarian cancer	5.26e-05	0.000577	CbGpPWpGaD
Bleomycin—Decreased appetite—Epirubicin—ovarian cancer	5.26e-05	0.00042	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—ovarian cancer	5.23e-05	0.000418	CcSEcCtD
Bleomycin—Pain—Epirubicin—ovarian cancer	5.17e-05	0.000414	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.1e-05	0.000408	CcSEcCtD
Bleomycin—Paraesthesia—Doxorubicin—ovarian cancer	5.03e-05	0.000402	CcSEcCtD
Bleomycin—Dyspnoea—Doxorubicin—ovarian cancer	4.99e-05	0.000399	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—ovarian cancer	4.99e-05	0.000399	CcSEcCtD
Bleomycin—BLMH—Immune System—KRAS—ovarian cancer	4.98e-05	0.000546	CbGpPWpGaD
Bleomycin—Decreased appetite—Doxorubicin—ovarian cancer	4.87e-05	0.000389	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.85e-05	0.000532	CbGpPWpGaD
Bleomycin—Urticaria—Epirubicin—ovarian cancer	4.81e-05	0.000384	CcSEcCtD
Bleomycin—Pain—Doxorubicin—ovarian cancer	4.79e-05	0.000383	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—ovarian cancer	4.78e-05	0.000382	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—ovarian cancer	4.72e-05	0.000517	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—ovarian cancer	4.67e-05	0.000512	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.62e-05	0.000506	CbGpPWpGaD
Bleomycin—Feeling abnormal—Doxorubicin—ovarian cancer	4.61e-05	0.000369	CcSEcCtD
Bleomycin—BLMH—Immune System—PIK3CA—ovarian cancer	4.57e-05	0.000501	CbGpPWpGaD
Bleomycin—Hypersensitivity—Epirubicin—ovarian cancer	4.46e-05	0.000356	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—ovarian cancer	4.45e-05	0.000356	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—ovarian cancer	4.43e-05	0.000354	CcSEcCtD
Bleomycin—Asthenia—Epirubicin—ovarian cancer	4.34e-05	0.000347	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MAPK3—ovarian cancer	4.34e-05	0.000476	CbGpPWpGaD
Bleomycin—LIG1—Disease—CAV1—ovarian cancer	4.32e-05	0.000474	CbGpPWpGaD
Bleomycin—Pruritus—Epirubicin—ovarian cancer	4.28e-05	0.000342	CcSEcCtD
Bleomycin—BLMH—Immune System—HRAS—ovarian cancer	4.23e-05	0.000464	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—ovarian cancer	4.22e-05	0.000463	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MAPK1—ovarian cancer	4.13e-05	0.000453	CbGpPWpGaD
Bleomycin—Hypersensitivity—Doxorubicin—ovarian cancer	4.12e-05	0.00033	CcSEcCtD
Bleomycin—LIG1—Disease—IL6ST—ovarian cancer	4.09e-05	0.000449	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL6—ovarian cancer	4.05e-05	0.000444	CbGpPWpGaD
Bleomycin—Asthenia—Doxorubicin—ovarian cancer	4.02e-05	0.000321	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—ovarian cancer	3.96e-05	0.000317	CcSEcCtD
Bleomycin—LIG1—Disease—APC—ovarian cancer	3.93e-05	0.000431	CbGpPWpGaD
Bleomycin—Vomiting—Epirubicin—ovarian cancer	3.85e-05	0.000308	CcSEcCtD
Bleomycin—Rash—Epirubicin—ovarian cancer	3.81e-05	0.000305	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—ovarian cancer	3.81e-05	0.000305	CcSEcCtD
Bleomycin—BLMH—Immune System—AKT1—ovarian cancer	3.74e-05	0.00041	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—ovarian cancer	3.59e-05	0.000287	CcSEcCtD
Bleomycin—Vomiting—Doxorubicin—ovarian cancer	3.56e-05	0.000285	CcSEcCtD
Bleomycin—Rash—Doxorubicin—ovarian cancer	3.53e-05	0.000282	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—ovarian cancer	3.53e-05	0.000282	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—ovarian cancer	3.47e-05	0.00038	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CD—ovarian cancer	3.46e-05	0.000379	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—ovarian cancer	3.33e-05	0.000266	CcSEcCtD
Bleomycin—LIG1—Disease—ERBB2—ovarian cancer	3.05e-05	0.000335	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CB—ovarian cancer	3.01e-05	0.000331	CbGpPWpGaD
Bleomycin—LIG1—Disease—MTOR—ovarian cancer	3.01e-05	0.000331	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1B—ovarian cancer	2.83e-05	0.00031	CbGpPWpGaD
Bleomycin—LIG1—Disease—CTNNB1—ovarian cancer	2.67e-05	0.000293	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—ovarian cancer	2.6e-05	0.000286	CbGpPWpGaD
Bleomycin—LIG1—Disease—STAT3—ovarian cancer	2.33e-05	0.000255	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—ovarian cancer	2.32e-05	0.000255	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAPK3—ovarian cancer	2.23e-05	0.000244	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—ovarian cancer	2.16e-05	0.000237	CbGpPWpGaD
Bleomycin—LIG1—Disease—MAPK1—ovarian cancer	2.12e-05	0.000232	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—ovarian cancer	2.12e-05	0.000232	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—ovarian cancer	2e-05	0.000219	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—ovarian cancer	1.84e-05	0.000201	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—ovarian cancer	1.7e-05	0.000186	CbGpPWpGaD
Bleomycin—LIG1—Disease—IL6—ovarian cancer	1.63e-05	0.000178	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—ovarian cancer	1.5e-05	0.000165	CbGpPWpGaD
